# ClinicalTrials.gov record NCT01971242

> PeptideScanner retained ClinicalTrials.gov record NCT01971242 at 2026-07-30T21:34:56.502Z. Its registry update date was 2016-11-17, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct01971242-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-11-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01971242-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01971242-exenatide-v1.json
- Content SHA-256: `dbf31f6377e564517a0f0a69ee99a6f022d09b05f39d69636fbfc1679c3becc1`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01971242 ([`ctg-observation-nct01971242-2016-11-17-4d4f08b2f251`](#source-ctg-observation-nct01971242-2016-11-17-4d4f08b2f251))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01971242 at 2026-07-30T21:34:56.502Z. Its registry update date was 2016-11-17, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01971242-2016-11-17-4d4f08b2f251`](#source-ctg-observation-nct01971242-2016-11-17-4d4f08b2f251))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01971242 at 2026-07-30T21:34:56.502Z. Its registry update date was 2016-11-17, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct01971242-2016-11-17-4d4f08b2f251`](#source-ctg-observation-nct01971242-2016-11-17-4d4f08b2f251))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01971242-2016-11-17-4d4f08b2f251`](#source-ctg-observation-nct01971242-2016-11-17-4d4f08b2f251))

## Sources

<a id="source-ctg-observation-nct01971242-2016-11-17-4d4f08b2f251"></a>
- **ClinicalTrials.gov record NCT01971242 · retained source version 2016-11-17:4d4f08b2f25187bf6e1fd73fd678c846a840551049bfceaf3fef874766a1f262** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01971242) (`ctg-observation-nct01971242-2016-11-17-4d4f08b2f251`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01971242." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01971242-exenatide-v1.json SHA-256: dbf31f6377e564517a0f0a69ee99a6f022d09b05f39d69636fbfc1679c3becc1.